Merus NV (MRUS): Among the Most Promising Cancer Stocks According to Hedge Funds

Published on 23 Nov 2024 on Insider Monkey · via Yahoo Finance

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this...

Read the rest of the article

Start tracking your investments with Statfolio

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 17 Jan 2025

We recently published a list of Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight. In...

Insider Monkey · via Yahoo Finance 10 Dec 2024

On Wednesday, the FDA approved Merus N.V.’s (NASDAQ:MRUS) Bizengri (zenocutuzumab-zbco) as the fi...

Benzinga · via AOL 6 Dec 2024

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Merus N.V. MRUS is still “very, very specu...

Benzinga 5 Dec 2024

Merus N.V. (NASDAQ:MRUS) and Partner Therapeutics Inc, a private biotechnology company focused on...

Benzinga · via AOL 3 Dec 2024

Merus N.V. (NASDAQ:MRUS) and Partner Therapeutics Inc, a private biotechnology company focused on...

Benzinga · via Yahoo Finance 3 Dec 2024

U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Monday. Shares o...

Benzinga 2 Dec 2024

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In t...

Insider Monkey · via Yahoo Finance 23 Nov 2024

We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this...

Insider Monkey · via Yahoo Finance 14 Nov 2024

Key Insights Significantly high institutional ownership implies Merus' stock price is sensitive t...

Simply Wall St. · via Yahoo Finance 21 Jul 2024